ONCOTHERAPY SCIENCE, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16 JPY | 0.00% |
|
-5.88% | -30.43% |
| Apr. 29 | Poland's Tusk calls prosecutor over potential Orlen scandal | RE |
| Apr. 22 | OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Bio Therapeutic Drugs | 0.00% | -5.88% | -30.43% | -57.89% | -85.05% | 22.29M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- 4564 Stock
- Charts OncoTherapy Science, Inc.
- Comparison Chart
